Langenberg AG - Search Results

1

Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.

Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, Tyring S, Douglas JM Jr, Corey L. Wald A, et al. Among authors: langenberg ag. JAMA. 2001 Jun 27;285(24):3100-6. doi: 10.1001/jama.285.24.3100. JAMA. 2001. PMID: 11427138 Clinical Trial.

2

The relationship between condom use and herpes simplex virus acquisition.

Wald A, Langenberg AG, Krantz E, Douglas JM Jr, Handsfield HH, DiCarlo RP, Adimora AA, Izu AE, Morrow RA, Corey L. Wald A, et al. Among authors: langenberg ag. Ann Intern Med. 2005 Nov 15;143(10):707-13. doi: 10.7326/0003-4819-143-10-200511150-00007. Ann Intern Med. 2005. PMID: 16287791 Clinical Trial.

3

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.

Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM Jr, Handsfield HH, Warren T, Marr L, Tyring S, DiCarlo R, Adimora AA, Leone P, Dekker CL, Burke RL, Leong WP, Straus SE. Corey L, et al. Among authors: langenberg ag. JAMA. 1999 Jul 28;282(4):331-40. doi: 10.1001/jama.282.4.331. JAMA. 1999. PMID: 10432030 Clinical Trial.

4

Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection.

Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Langenberg A, et al. Ann Intern Med. 1989 Jun 1;110(11):882-7. doi: 10.7326/0003-4819-110-11-882. Ann Intern Med. 1989. PMID: 2541645

5

A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.

Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, Kamb M, Wald A. Martin ET, et al. Arch Intern Med. 2009 Jul 13;169(13):1233-40. doi: 10.1001/archinternmed.2009.177. Arch Intern Med. 2009. PMID: 19597073 Free PMC article.

6

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial.

Straus SE, Wald A, Kost RG, McKenzie R, Langenberg AG, Hohman P, Lekstrom J, Cox E, Nakamura M, Sekulovich R, Izu A, Dekker C, Corey L. Straus SE, et al. Among authors: langenberg ag. J Infect Dis. 1997 Nov;176(5):1129-34. doi: 10.1086/514103. J Infect Dis. 1997. PMID: 9359709 Clinical Trial.

7

Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine.

Ashley RL, Crisostomo FM, Doss M, Sekulovich RE, Burke RL, Shaughnessy M, Corey L, Polissar NL, Langenberg AG. Ashley RL, et al. Among authors: langenberg ag. J Infect Dis. 1998 Jul;178(1):1-7. doi: 10.1086/515611. J Infect Dis. 1998. PMID: 9652416

8

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. Langenberg AG, et al. N Engl J Med. 1999 Nov 4;341(19):1432-8. doi: 10.1056/NEJM199911043411904. N Engl J Med. 1999. PMID: 10547406 Free article.

9

Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.

Koelle DM, Benedetti J, Langenberg A, Corey L. Koelle DM, et al. Ann Intern Med. 1992 Mar 15;116(6):433-7. doi: 10.7326/0003-4819-116-6-433. Ann Intern Med. 1992. PMID: 1310837 Free PMC article.

10

Detection of herpes simplex virus DNA from genital lesions by in situ hybridization.

Langenberg A, Smith D, Brakel CL, Pollice M, Remington M, Winter C, Dunne A, Corey L. Langenberg A, et al. J Clin Microbiol. 1988 May;26(5):933-7. doi: 10.1128/jcm.26.5.933-937.1988. J Clin Microbiol. 1988. PMID: 2838505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page